This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: The Rockefeller University. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: The Innovations of Marc Flajolet
Introduction
Marc Flajolet is a notable inventor based in New York, NY (US). He has made significant contributions to the field of medical research, particularly in the treatment of disorders related to A-β peptides, which are associated with Alzheimer's disease. His innovative approach has led to the development of methods that could potentially improve the lives of many patients.
Latest Patents
Marc Flajolet holds a patent for "Methods for the treatment of A-β related disorders and compositions therefor." This invention provides methods for treating Aβ peptide-related disorders, such as Alzheimer's disease, by administering a therapeutically effective amount of a CK1 modulator to a patient in need thereof. This patent highlights his commitment to advancing medical science and finding solutions for complex health issues.
Career Highlights
Throughout his career, Marc has worked with prestigious institutions, including The Rockefeller University and Manros Therapeutics. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of Marc Flajolet's notable coworkers include Paul Greengard and Nassima Oumata. Their collaboration has likely enriched his research and innovation efforts, fostering an environment of shared knowledge and expertise.
Conclusion
Marc Flajolet's contributions to the field of medical research, particularly through his patent on A-β related disorders, demonstrate his dedication to innovation and improving patient care. His work continues to inspire future advancements in the treatment of Alzheimer's disease and related conditions.